News Sentiment

BMRN sentiment intelligence

BioMarin Pharmaceutical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 19 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 959.00 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 19

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

BioMarin stock trades steady as rare disease revenue grows and gene therapy outlook develops

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 0.0% over four weeks
Fair value -29.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 14
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 19
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
PR Newswire 6
Market source 5
ChartMill 3
Ad-hoc-news.de 1
simplywall.st 1
Stock Titan 1
Reuters 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 10
Earnings 6
Analyst action 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-19 of 19